Making What’s Next in Medicine: Why Research at Penn Powers Many FDA-Approved Treatments
Penn Medicine is a place that incubates and brings to life some of the most transformative modern medical advancements. Science has shifted toward more discoveries based on the underlying mechanism of disease, especially in new cancer drug discovery.
Breakthroughs, Practice-Changing Data Expected at AACR 2023
Robert H. Vonderheide, MD, DPhil, director of the ACC, explained, “This conference [AACR 2023] is about new ideas, new progress, and new findings. We have already made so much progress in cancer research, but it has only just begun."
AACR Annual Meeting 2023 Overview: Advancing the Frontiers of Cancer Science and Medicine
“From cutting-edge basic science and translational science all the way into population science, we’re going to learn about trial results that will change practice,” Robert H. Vonderheide, MD, DPhil, director of the Penn Medicine ACC said.
Penn Medicine Research Suggests More Cancers Can Be Treated with Drugs Than Previously Believed
Gregory R. Bowman, PhD, a Penn professor of Biochemistry and Biophysics and Bioengineering, leads a study as the first researcher funded by the Basser Cancer Interception Institute (BCII) to support his ongoing work to BRCA-related research.
Program Covers the Hottest Topics in Cancer Research
AACR Program Committee Chair Robert H. Vonderheide, MD, DPhil, Director of the Abramson Cancer Center is excited for the topics that will be covered at the 2023 AACR Annual Meeting.
Penn Medicine at the AACR Annual Meeting 2023
Penn Medicine researchers will present four plenary sessions at the AACR – including remarks from the 2023 Annual Meeting Program Committee Chair Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center.
The 2023 Health Care Power 100
City & State’s 2023 Health Care Power 100 highlights Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center, on framing, influencing, and trying to change the conversation around health care in Pennsylvania.
Educated Patient Breast Cancer Summit at MBCC Precision Medicine Panel
Basser Center executive director Dr. Susan Domchek participated in a panel discussion about precision medicine at the CURE Educated Patient Breast Cancer Summit.
Discussing Genetic Testing and Precision Medicine for Cancer
Susan M. Domchek, MD, executive director of the Basser Center, presented at the CURE Educated Patient Breast Cancer Summit.
Abramson Cancer Center Leader Outlines Immunotherapy Advances
“We need to look at cancer vaccines to prevent disease or prevent relapse — to intercept cancer,” said Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center.